Bio-Path Inc., a privately held company based in Ogden and Texas, has merged with Ogden Golf Co. Corp., a public company also based in Ogden.
The combined company is Bio-Path Holdings Inc. and its common stock is trading under the symbol BPTH.
Ogden shareholders will receive one share of Bio-Path common stock for each Ogden share, and Bio-Path shareholders received a conversion ratio of approximately 2.2 shares of Ogden common stock for each share of Bio-Path common stock. As a result, Ogden shareholders will own about 8.65 percent of Bio-Path and the Bio-Path shareholders received about 91.3 percent of the newly outstanding shares after the merger.
Bio-Path is developing a drug delivery system for the treatment of cancer.